Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Myelodysplastic Syndromes – Access & Reimbursement – Access & Reimbursement – Myelodysplastic Syndromes (US)
Myelodysplastic syndromes (MDS) are a heterogeneous collection of hematopoietic stem cell disorders that result in cytopenias. Based on our survey results, the U.S. reimbursement environment…
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma | Unmet Need | Previously Treated, Metastatic | US/EU | 2020
While the incidence of gastric and GEJ adenocarcinoma continues to rise, efficacious treatment options, especially in the previously treated metastatic setting, remain limited. Cyramza (Eli Lilly)…